Lataa...
Targeting B-cell maturation antigen in multiple myeloma
Novel effective immunotherapies are needed for patients with multiple myeloma (MM), since disease recurrence remains a major obstacle. B-cell maturation antigen (BCMA), a cell surface protein universally expressed on malignant plasma cells , has emerged as a very selective antigen to be targeted in...
Tallennettuna:
| Julkaisussa: | Immunotherapy |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Future Medicine Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976846/ https://ncbi.nlm.nih.gov/pubmed/26370838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.77 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|